4.5 Article

The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect

Journal

CELLULAR IMMUNOLOGY
Volume 281, Issue 1, Pages 62-67

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2013.01.001

Keywords

Prostaglandin E-2; IDO; Dendritic cell; Cancer vaccine; Tumor-induced immunosuppression

Funding

  1. Max-Eder junior Research Group Program of the Deutsche Krebshilfe
  2. Else Kroner-Fresenius-Stiftung [P68/08//A50/08]

Ask authors/readers for more resources

Prostaglandin E-2 has been shown to enhance the maturation, migration, and antigen-presenting capacity of DCs. It is therefore included in many maturation cocktails for the generation of monocyte-derived DCs. Paradoxically, PGE(2) is also an important tumor-derived immunosuppressive factor and has inhibitory effects on DC differentiation and function. To further investigate these seemingly contradictory results we studied whether the DC:T cell ratio has an impact on the outcome of the interaction between PGE(2)-treated DCs and T cells. Surprisingly, at high DC:T cell ratios T cell proliferation was inhibited while at low ratios PGE(2)-treated DCs displayed enhanced T cell-stimulatory properties. The inhibitory function of PGE(2)-treated DCs depended primarily on the PGE(2)-induced induction of indoleamine 2,3-dioxygenase competence. In summary, we show that PGE(2)-treated DCs can have either an immunogenic or tolerogenic function depending on the DC:T cell ratio. This finding could explain the conflicting results regarding the influence of PGE(2) on DC function. (c) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available